FLG and Alzheimer disease: In that evaluation, FLG mutations made no significant difference in maintaining the remission phase between AD exacerbation (−) and AD exacerbation, suggesting that there might be no correlation between the existence of FLG mutations and the efficacy of P-Cer skin care.